Marksans Pharma informs about press release
Marksans Pharma has informed that its wholly owned subsidiary Relonchem in UK has received Marketing Authorization for its following products from UK MHRA: 1. Mefenamic Acid 250 mg Film-Coated Tablets, 2. Mefenamic Acid 500 mg Film-Coated Tablets.
The above information is a part of company’s filings submitted to BSE.
